Literature DB >> 28831978

40 years of percutaneous coronary intervention: where next?

.   

Abstract

Year:  2017        PMID： 28831978     DOI： 10.1016/S0140-6736(17)32238-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Circulating miR-660-5p is associated with no-reflow phenomenon in patients with ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Authors:  Jianwei Zhang; Lingjie He
Journal:  Anatol J Cardiol       Date:  2021-05       Impact factor: 1.596

2.  The Elevated Soluble ST2 Predicts No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Authors:  Mustafa Umut Somuncu; Tunahan Akgun; Mustafa Ozan Cakır; Ferit Akgul; Nail Guven Serbest; Huseyin Karakurt; Murat Can; Ali Riza Demir
Journal:  J Atheroscler Thromb       Date:  2019-04-18       Impact factor: 4.928

3.  The Value of Pre-Infarction Angina and Plasma D-Dimer in Predicting No-Reflow After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction Patients.

Authors:  Hongyu Zhang; Baohua Qiu; Yan Zhang; Yanjun Cao; Xia Zhang; Zhiguo Wu; Shujing Wang; Lianlian Mei
Journal:  Med Sci Monit       Date:  2018-07-01

4.  A Nomogram Based on Apelin-12 for the Prediction of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention among Patients with ST-Segment Elevation Myocardial Infarction.

Authors:  Enfa Zhao; Hang Xie; Yushun Zhang
Journal:  Cardiovasc Ther       Date:  2020-02-06       Impact factor: 3.023
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.